Streamer said ‘deal no longer financially attractive’ at price required to match offer by David Ellison’s firm
Последние новости
，推荐阅读爱思助手下载最新版本获取更多信息
Accept and continue
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
This Tweet is currently unavailable. It might be loading or has been removed.